Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Ebastine may help regrow hair in alopecia areata patients.

People with alopecia areata are more likely to have other immune-related conditions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Dupilumab may worsen hair loss in patients with alopecia areata.

The study developed a successful mouse model to study skin infections, highlighting the importance of choosing the right fungal strains.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.